Daniel Pichl is Chief People Officer of SpringWorks Therapeutics, Inc.. Currently has a direct ownership of 45,212 shares of SWTX, which is worth approximately $1.5 Million. The most recent transaction as insider was on Feb 16, 2024, when has been sold 15,000 shares (Common Stock) at a price of $50.1 per share, resulting in proceeds of $751,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 45.2K
0% 3M change
28.43% 12M change
Total Value Held $1.5 Million

Daniel Pichl Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 16 2024
SELL
Open market or private sale
$751,500 $50.1 p/Share
15,000 Reduced 24.91%
45,212 Common Stock
Feb 16 2024
BUY
Exercise of conversion of derivative security
$414,600 $27.64 p/Share
15,000 Added 19.94%
60,212 Common Stock
Feb 02 2024
SELL
Open market or private sale
$1,181,548 $45.13 p/Share
26,181 Reduced 36.67%
45,212 Common Stock
Feb 02 2024
BUY
Exercise of conversion of derivative security
$449,150 $27.64 p/Share
16,250 Added 18.54%
71,393 Common Stock
Jan 08 2024
SELL
Payment of exercise price or tax liability
$58,349 $41.53 p/Share
1,405 Reduced 2.48%
55,143 Common Stock
Jan 05 2024
SELL
Payment of exercise price or tax liability
$59,749 $37.96 p/Share
1,574 Reduced 2.71%
56,548 Common Stock
Jan 04 2024
BUY
Grant, award, or other acquisition
-
22,919 Added 28.28%
58,122 Common Stock
Jan 26 2023
SELL
Open market or private sale
$26,598 $31.0 p/Share
858 Reduced 2.38%
35,203 Common Stock
Jan 07 2023
SELL
Payment of exercise price or tax liability
$14,419 $26.41 p/Share
546 Reduced 1.49%
36,061 Common Stock
Jan 06 2023
SELL
Payment of exercise price or tax liability
$47,306 $27.52 p/Share
1,719 Reduced 4.49%
36,607 Common Stock
Jan 05 2023
BUY
Grant, award, or other acquisition
-
19,425 Added 33.64%
38,326 Common Stock
Jan 07 2022
SELL
Payment of exercise price or tax liability
$47,203 $56.06 p/Share
842 Reduced 3.78%
21,456 Common Stock
Jan 06 2022
BUY
Grant, award, or other acquisition
-
13,062 Added 36.94%
22,298 Common Stock
Sep 08 2021
BUY
Exercise of conversion of derivative security
$99,992 $43.1 p/Share
2,320 Added 20.08%
9,236 Common Stock
Jan 07 2021
BUY
Grant, award, or other acquisition
-
4,150 Added 50.0%
4,150 Common Stock
DP

Daniel Pichl

Chief People Officer
Stamford, CT

Track Institutional and Insider Activities on SWTX

Follow SpringWorks Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SWTX shares.

Notify only if

Insider Trading

Get notified when an Spring Works Therapeutics, Inc. insider buys or sells SWTX shares.

Notify only if

News

Receive news related to SpringWorks Therapeutics, Inc.

Track Activities on SWTX